Methods for treating sleep apnea and sleep induced apnea using optically pure (+) norcisapride
US6835740B2 · kind B2 · utility
17Cited by
25References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 15, 2002 |
| Grant date | Dec 28, 2004 |
| Priority date | — |
| Expiry date | Mar 23, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods for the prevention, treatment, or management of apnea, apnea disorders, bulimia, nervosa, irritable bowel syndrome, urinary incontinence, bradycardia, bradyarrhythmia, syncope, other disorders, or symptoms thereof using (+) norcisapride, or a pharmaceutically acceptable salt thereof, substantially free of its (−) stereoisomer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.